{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:28:58Z","timestamp":1783427338374,"version":"3.54.6"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse, NIH","doi-asserted-by":"crossref","award":["T32 GM-077067"],"award-info":[{"award-number":["T32 GM-077067"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.neuropharm.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T15:46:45Z","timestamp":1536076005000},"page":"296-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Role of hippocampal 5-HT1A receptors in the antidepressant-like phenotype of mice expressing RGS-insensitive G\u03b1i2 protein"],"prefix":"10.1016","volume":"141","author":[{"given":"Nicolas B.","family":"Senese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Oginsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Neubig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Ferrario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Jutkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Traynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.09.002_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1113\/jphysiol.1987.sp016862","article-title":"Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro","volume":"394","author":"Andrade","year":"1987","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0165-6147(93)90125-4","article-title":"5-HT and antidepressants: new views from microdialysis studies","volume":"14","author":"Artigas","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0092-8674(00)80117-8","article-title":"GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits","volume":"86","author":"Berman","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib4","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1016\/S0021-9258(18)42427-1","article-title":"Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits","volume":"267","author":"Bertin","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.brainres.2004.06.073","article-title":"Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo","volume":"1022","author":"Beyer","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/acschemneuro.5b00063","article-title":"Selectivity and anti-Parkinson\u2019s potential of thiadiazolidinone RGS4 inhibitors","volume":"6","author":"Blazer","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib7","first-page":"37","article-title":"Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain","volume":"26","author":"Blier","year":"2001","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(25)38146-2","article-title":"Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone","volume":"265","author":"Blier","year":"1993","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.neuropharm.2008.09.004","article-title":"Region-specific changes in 5-HT1A agonist-induced Extracellular signal-Regulated Kinases 1\/2 phosphorylation in rat brain: a quantitative ELISA study","volume":"56","author":"Buritova","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1167\/iovs.09-4084","article-title":"Functional redundancy of R7 RGS proteins in ON-bipolar cell dendrites","volume":"51","author":"Chen","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib12","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1074\/jbc.M208885200","article-title":"Endogenous RGS Protein Action Modulates \u03bc-Opioid Signaling through G\u03b1o","volume":"278","author":"Clark","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/328073a0","article-title":"Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin","volume":"328","author":"Colino","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib14","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Council","year":"2011"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00210-002-0586-2","article-title":"Prolonged corticosterone treatment alters the responsiveness of 5-HT 1A receptors to 8-OH-DPAT in rat CA1 hippocampal neurons","volume":"366","author":"Czyrak","year":"2002","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib16","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1101\/gad.14.16.2003","article-title":"Multiple RGS proteins alter neural G protein signaling to allow C. elegans to rapidly change behavior when fed","volume":"14","author":"Dong","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0167-4781(01)00342-6","article-title":"Profile of RGS expression in single rat atrial myocytes","volume":"1522","author":"Doupnik","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.RES.0000207497.50477.60","article-title":"Endogenous RGS proteins and G subtypes differentially control muscarinic and adenosine-mediated chronotropic effects","volume":"98","author":"Fu","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib19","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0076-6879(04)89014-1","article-title":"RGS-insensitive G-protein mutations to study the role of endogenous RGS proteins","author":"Fu","year":"2004"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.cellsig.2003.11.006","article-title":"Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity","volume":"16","author":"Ghavami","year":"2004","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib21","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1523\/JNEUROSCI.17-20-08024.1997","article-title":"Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain","volume":"17","author":"Gold","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib22","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1124\/mol.108.054296","article-title":"Regulator of G protein signaling protein suppression of Galphao protein-mediated alpha2A adrenergic receptor inhibition of mouse hippocampal CA3 epileptiform activity","volume":"75","author":"Goldenstein","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0169-328X(01)00038-9","article-title":"Regional distribution of regulators of G-protein signaling (RGS) 1, 2, 13, 14, 16, and GAIP messenger ribonucleic acids by in situ hybridization in rat brain","volume":"88","author":"Grafstein-Dunn","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF02244281","article-title":"Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on core temperature in the rat","volume":"103","author":"Hillegaart","year":"1991","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/026988110001400208","article-title":"Serotonin autoreceptor function and antidepressant drug action","volume":"14","author":"Hjorth","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1124\/pr.54.3.527","article-title":"Cellular regulation of RGS proteins: modulators and integrators of G protein signaling","volume":"54","author":"Hollinger","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib27","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1128\/MCB.00314-06","article-title":"Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele","volume":"26","author":"Huang","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib28","first-page":"102","article-title":"Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique","volume":"40","author":"Ito","year":"1999","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib29","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nn.4293","article-title":"Serotonin modulates spike probability in the axon initial segment through HCN channels","volume":"19","author":"Ko","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1124\/mol.106.022756","article-title":"Regional differences in the coupling of 5-hydroxytryptamine-1a receptors to G proteins in the rat brain","volume":"70","author":"la Cour","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib31","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1523\/JNEUROSCI.5470-12.2013","article-title":"Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive G\u03b1o protein","volume":"33","author":"Lamberts","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib32","doi-asserted-by":"crossref","first-page":"12794","DOI":"10.1074\/jbc.273.21.12794","article-title":"A point mutation in Galphao and Galphai1 blocks interaction with regulator of G protein signaling proteins","volume":"273","author":"Lan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0014-2999(94)90812-5","article-title":"Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse","volume":"271","author":"Laporte","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.brainres.2005.12.066","article-title":"Comparison of the in vitro efficacy of \u03bc, \u03b4, \u03ba and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes","volume":"1073\u20131074","author":"Lester","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib35","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0006-8993(09)90010-5","article-title":"Localization and gene expression of serotonin 1A (5HT1A) receptors in human brain postmortem","volume":"658","author":"Marazziti","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1476-5381.2008.00001.x","article-title":"Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist","volume":"156","author":"Newman-Tancredi","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib38","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1152\/jn.1995.74.5.2189","article-title":"G alpha o1 decapeptide modulates the hippocampal 5-HT1A potassium current","volume":"74","author":"Oleskevich","year":"1995","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0893-133X(00)00109-3","article-title":"\u03b2-Blocker binding to human 5-HT1A receptors in vivo and in vitro implications for antidepressant therapy","volume":"23","author":"Rabiner","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0893-133X(95)00240-E","article-title":"Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain","volume":"15","author":"Romero","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib42","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1096\/fj.13-235648","article-title":"Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT1A receptor-adenylyl cyclase axis","volume":"28","author":"Stewart","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib43","doi-asserted-by":"crossref","first-page":"8254","DOI":"10.1073\/pnas.1214696110","article-title":"Regulator of G protein signaling 4 is a crucial modulator of antidepressant drug action in depression and neuropathic pain models","volume":"110","author":"Stratinaki","year":"2013","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib44","doi-asserted-by":"crossref","first-page":"11086","DOI":"10.1073\/pnas.1000003107","article-title":"RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects","volume":"107","author":"Talbot","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0092-8674(00)80204-4","article-title":"Structure of RGS4 bound to AlF4-activated G(i alpha1): stabilization of the transition state for GTP hydrolysis","volume":"89","author":"Tesmer","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2018.09.002_bib46","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.tpj.6500486","article-title":"Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder","volume":"8","author":"Tsai","year":"2008","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/ml200263y","article-title":"Small molecule inhibitors of regulators of G protein signaling (RGS) proteins","volume":"3","author":"Turner","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2018.09.002_bib48","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.cellsig.2014.04.017","article-title":"5-HT1A receptor-mediated phosphorylation of extracellular signal-regulated kinases (ERK1\/2) is modulated by regulator of G protein signaling protein 19","volume":"26","author":"Wang","year":"2014","journal-title":"Cell. Signal."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T21:17:42Z","timestamp":1751836662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818306154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":48,"alternative-id":["S0028390818306154"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.002","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of hippocampal 5-HT1A receptors in the antidepressant-like phenotype of mice expressing RGS-insensitive G\u03b1i2 protein","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}